April 18, 2017
Cerenis Therapeutics announces the initiation of the Phase 1 clinical study with CER-209 in NAFLD and NASH
Media
April 11, 2017
BONESUPPORT™ appoints Michael Diefenbeck as Chief Medical Officer
April 06, 2017
Report from Orexo AB´s annual general meeting, April 6 2017
April 06, 2017
Targovax to present clinical data on its phase I/II clinical trial evaluating TG01 in resected pancreatic cancer at the ASCO Annual Meeting
April 05, 2017
Final Phase 2 results for WTX101 accepted as a late-breaker presentation at EASL Annual Meeting
March 31, 2017
Exercise of the over-allotment option
March 28, 2017
Altimmune Receives $7.3 Million Contract Modification from BARDA to Fund Manufacturing of its First-In-Class Anthrax Vaccine Candidate NasoShield™
March 28, 2017
GenSight Biologics to Present Data on GS010 at the 43rd Annual Meeting of NANOS
March 27, 2017
Strongbridge Biopharma plc Provides Corporate Update and Reports Full-Year 2016 Financial Results
March 24, 2017
Nordic Nanovector publishes Annual Report 2016